BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//White City Innovation District - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:White City Innovation District
X-ORIGINAL-URL:https://www.whitecityinnovationdistrict.org.uk
X-WR-CALDESC:Events for White City Innovation District
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251212T100000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20260422T211536
CREATED:20251210T130320Z
LAST-MODIFIED:20251210T130320Z
UID:4024-1765533600-1765558800@www.whitecityinnovationdistrict.org.uk
SUMMARY:Creative Disruption: AI & Next-Gen Therapies - What’s coming in 2026?
DESCRIPTION:Get ready to shake up the future of AI\, advanced therapies\, and biologics at #CreativeDisruption – it’s going to be truly thought-provoking! \n\n\n\n\nWant to hear what sector’s most influential thinkers say about where AI and next-gen therapies are heading in 2026? \nAI is rapidly reshaping emerging biotech\, advanced therapies and biologics in the UK. Machine learning now enables the analysis of large and complex datasets\, supporting the discovery of new biomarkers and therapeutic targets and improving the modelling of biological responses. This leads to more precise and better targeted biologics and advanced therapies. \nUK biotech organisations are also forming deeper partnerships with technology companies to access advanced data analytics and embed AI more effectively into research pipelines. Government backed initiatives are strengthening this progress and accelerating innovation. \nAI driven drug repurposing is gaining momentum\, helping redirect existing compounds to new indications\, reducing development timelines and improving cost efficiency. With these advances accelerating\, the UK remains strongly positioned to lead in biologics and advanced therapies both scientifically and commercially. \nChatham House Rules apply – “what goes on in the Forum\, stays in the Forum – so to speak!” \nWho Should Attend \nThe #CreativeDisruption Forum is designed for professionals working in life sciences who are driving innovation and growth. It is ideal for: \n\nFounders and executives of biotech\, medtech\, and healthtech companies\nR&D and clinical development leaders\nInvestors and business strategists in the healthcare sector\nInnovation managers\, consultants\, and academic partners involved in commercialisation\nStudents and early-career researchers interested in understanding how scientific innovation translates into successful business ventures\n\nSchedule: \n10.00 – 10.30 – Arrival and Networking \n10.30 – 10.50 – Introductions to ARC West London (Andrew Davies and Deborah Spencer)\, ThermoFisher (Ashley Box and Patrick Arnott)\, TCR Solutions (Peter Maclennan and Davy Yeung) Digipac Consultancy (Kamile Iris Ozbek\, Nilsu Pinar and Cansu Akyar) \n10.50- 10.55 – Cllr Stephen Cowan\, Leader of the London Borough of Hammersmith & Fulham – to talk about the Upstream London initiative \n10.55 – 11.25 – Keynote Session: How Emerging Biotechs Should Utilise Existing AI with Amjad Khan (Pfizer and Changely.AI) & Shabnam Raja (Cognizant) & Vik Khuana (Bristows LLC). \n11.20-11.35 – Keynote Session: Chiara Bruckman\, Process & Analytical Development\, Thermo Fisher Scientific – challenges & trends in mRNA Development \n11.35 – 12.10 – Keynote Session: Latest Trends in Biologics Companies \nChiara Bruckman\, ThermoFisher Scientific \nAndrew Buchanan\, Stealth Biotech \nChris Ulman\, Stratosvir \nJeff Drew\, Kindling Bio \n12.10-12.30 – Coffee Break & Networking \n12.30 – 13.00 – Keynote Session: Strategies for Advanced Therapeutics Companies \nProf Alan Boyd\, Boyds \nKerstin Papenfuss\, Deep Science Ventures \nAleks Guvenel\, Quell Therapeutics \nPedro Correa de Sampaio\, Neobe Therapeutics \n13.00 – 13.30 – Keynote Session: Field Insights from Leading Companies \nDavid Boothe\, Exert Therapeutics \nJoe Healy\, NanoSyrinx \nDavid Findlay\, Rostra Therapeutics \nJames Catt\, Imphatech \nDan Gooding\, Nuformix plc \n13.30 – 14.30 – Lunch Break and networking \n14.30 – 15.15 – Workshops \n15.15 – 15.45 – Workshop Group Leader Presentations \n15.45 – 16.00 – Closing with Prof. Tony Sedgwick \n16.00 – 17:00 – Networking and Drinks at ARC Hammersmith \n17:00 – Onwards – Unofficial Drinks at The Blue Boat (BYO – Buy Your Own)
URL:https://www.whitecityinnovationdistrict.org.uk/event/creative-disruption-ai-next-gen-therapies-whats-coming-in-2026/
LOCATION:ARC West London\, Manbre Wharf\, Manbre Road\, London\, W6 9RH\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://www.whitecityinnovationdistrict.org.uk/wp-content/uploads/sites/10/2025/12/ARC-Refinery-Brochure-117-scaled-1.jpg
END:VEVENT
END:VCALENDAR